ISHARES TR - ISHARES BIOTECH (IBB)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / ISHARES BIOTECH
Shares, excl. options Q1 2024
33.8 M
Holdings value Q1 2024
$4.64 B
Value change Q1 2024
+$327 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
859
Number of buys Q1 2024
327
Number of sells Q1 2024
-358
Average buys Q1 2024 %
+0.006%
Average sells Q1 2024 %
-0.003%
CUSIP
464287556
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 33.8 M $4.64 B +$327 M $137.22 860
2023 Q4 31.5 M $4.27 B -$393 M $135.85 848
2023 Q3 37 M $4.53 B -$193 M $122.29 814
2023 Q2 38.5 M $4.89 B -$181 M $126.96 819
2023 Q1 37.8 M $4.88 B -$572 M $129.16 841
2022 Q4 42.9 M $5.64 B +$658 M $131.29 878
2022 Q3 38.1 M $4.46 B -$62.1 M $116.96 809
2022 Q2 38.7 M $4.55 B -$141 M $117.63 834
2022 Q1 39.8 M $5.18 B -$36.7 M $130.30 869
2021 Q4 39.5 M $6.02 B -$361 M $152.62 938
2021 Q3 41 M $6.63 B -$483 M $161.68 837
2021 Q2 44.1 M $7.22 B -$738 M $163.65 844
2021 Q1 49.2 M $7.41 B -$1.31 B $150.56 832
2020 Q4 58.3 M $8.83 B +$1.02 B $151.49 840
2020 Q3 51.6 M $6.98 B -$453 M $135.41 770
2020 Q2 54.6 M $7.47 B +$1.17 B $136.69 754
2020 Q1 45.9 M $4.95 B -$725 M $107.74 646
2019 Q4 52.3 M $6.31 B -$7.82 M $120.51 700
2019 Q3 50.7 M $5.04 B -$6.24 M $99.50 590
2019 Q2 50.6 M $5.52 B +$176 M $109.10 642
2019 Q1 48.9 M $5.47 B +$248 M $111.80 656
2018 Q4 47.1 M $4.55 B -$271 M $96.43 636
2018 Q3 49.6 M $6.05 B -$538 M $121.94 634
2018 Q2 54 M $5.93 B +$255 M $109.82 604
2018 Q1 53.1 M $5.67 B -$16.8 M $106.74 609
2017 Q4 53.4 M $5.7 B +$3.31 B $106.77 624
2017 Q3 19.3 M $6.44 B +$612 M $333.59 582
2017 Q2 17.5 M $5.44 B +$99.4 M $310.08 561
2017 Q1 17.1 M $5.03 B +$496 M $293.27 522
2016 Q4 15.5 M $4.12 B -$147 M $265.38 521
2016 Q3 16 M $4.6 B +$577 M $289.46 464
2016 Q2 14.5 M $3.72 B -$163 M $257.34 427
2016 Q1 14.8 M $3.84 B -$449 M $260.81 419
2015 Q4 16.4 M $5.54 B -$1.68 B $338.33 431
2015 Q3 21.2 M $6.42 B +$1.1 B $303.33 415
2015 Q2 17.9 M $6.61 B -$268 M $368.97 434
2015 Q1 18.7 M $6.41 B +$719 M $343.43 407
2014 Q4 16.7 M $5.07 B -$691 M $303.35 377
2014 Q3 18.9 M $5.18 B +$605 M $273.63 320
2014 Q2 16.7 M $4.29 B -$590 M $257.03 308
2014 Q1 19.1 M $4.51 B +$1.29 B $236.40 301